Morgan Stanley
BITI

Morgan Stanley’s BIOTIE THERAPIES CORP SPONSORED ADR BITI Stock Holding History

Morgan Stanley’s Portfolio BITI Stock Details BITI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-153,001
Closed -$4.04M – 6872
2016
Q1 		$4.04M Buy
153,001
+152,901
+152,901% +$3.56M ﹤0.01% 2726
2015
Q4 		$1K Sell
100
-5,411
-98% -$75.7K ﹤0.01% 6616
2015
Q3 		$72K Buy
5,511
+4,776
+650% +$84K ﹤0.01% 5576
2015
Q2 		$15K Buy
+735
New +$15.3K ﹤0.01% 6213

Morgan Stanley's BITI Position: Q2 2016 in Review

Morgan Stanley sold out of BIOTIE THERAPIES CORP SPONSORED ADR (BITI) in Q2 2016, closing a stake of 153,001 shares — an estimated $4.04M sold.

Morgan Stanley first reported a position in BITI in Q2 2015 and held it in 4 quarters. The position peaked at $4.04M in Q1 2016. 0 funds tracked by Wall St. Rank hold BITI as of Q2 2016.

  • Morgan Stanley reported no remaining BIOTIE THERAPIES CORP SPONSORED ADR position as of Q2 2016 after selling out during the quarter.
  • Morgan Stanley sold 153,001 BIOTIE THERAPIES CORP SPONSORED ADR shares in Q2 2016, an estimated $4.04M.
  • Morgan Stanley first reported a position in BIOTIE THERAPIES CORP SPONSORED ADR in Q2 2015 and held it in 4 quarters.
  • Morgan Stanley's BIOTIE THERAPIES CORP SPONSORED ADR position peaked at $4.04M in Q1 2016.
  • 0 funds tracked by Wall St. Rank held BIOTIE THERAPIES CORP SPONSORED ADR as of Q2 2016.

Based on Morgan Stanley's 13F filing for Q2 2016, filed 12 Aug 2016.